Skip to main content
OpenTrials

Clinical trial condition

Carcinoma, Bronchogenic

Explore clinical trials studying Carcinoma, Bronchogenic. Study availability and eligibility vary by location and protocol.

5,226 public trials 1,176 recruiting studies
Refine in advanced search Browse all conditions

Carcinoma, Bronchogenic trial results

Active, Not Recruiting

A Real-World Assessment of the Demographic, Clinical Characteristics and Outcomes of a Brazilian Cohort of Previously Untreated Extensive Stage-Small Cell Lung Cancer Receiving Durvalumab Combined With Platinum-Etoposide in (ES-SCLC) in Brazil

NCT06008353

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Extensive-stage Small-cell Lung Cancer, +8 more
Locations
  • ÉTICA Clínica AMO - Assistência Multidisciplinar em Oncologia Salvador, Estado de Bahia, Brazil
  • Oncologia D'Or Unidade Esperança Pernambuco Recife, Pernambuco, Brazil
  • Instituto D'Or de Pesquisa e Ensino RJ Rio de Janeiro, Brazil
  • BP - A Beneficência Portuguesa de São Paulo São Paulo, Brazil
View Trial Details
Active, Not Recruiting

Tumor-specific T Cells in Lung Cancer

NCT02515760

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Division of Thoracic Surgery, Technical University of Munich, Munich, Germany Munich, Germany
View Trial Details
Active, Not Recruiting

Efficacy and Safety of Pembrolizumab (MK-3475) With Platinum Doublet Chemotherapy as Neoadjuvant/Adjuvant Therapy for Participants With Resectable Stage II, IIIA, and Resectable IIIB (T3-4N2) Non-small Cell Lung Cancer (MK-3475-671/KEYNOTE-671)

NCT03425643

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
Locations
  • Banner MD Anderson Cancer Center ( Site 0028) Gilbert, Arizona, United States
  • Western Regional Medical Center, Inc. ( Site 0050) Goodyear, Arizona, United States
  • University of Arizona Cancer Center - Dignity Health ( Site 0062) Phoenix, Arizona, United States
  • University of Arizona Cancer Center ( Site 0012) Tucson, Arizona, United States
View all 227 locations
View Trial Details
Active, Not Recruiting

Study of Pembrolizumab (MK-3475) Subcutaneous (SC) Versus Pembrolizumab Intravenous (IV) Administered With Platinum Doublet Chemotherapy in Participants With Metastatic Squamous or Nonsquamous Non-Small Cell Lung Cancer (NSCLC) (MK-3475-A86)

NCT04956692

Conditions
Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +9 more
Locations
  • St. Bernards Medical Center ( Site 0103) Jonesboro, Arkansas, United States
  • St Joseph Heritage Healthcare-Oncology ( Site 0102) Fullerton, California, United States
  • Cancer Blood and Specialty Clinic ( Site 0105) Los Alamitos, California, United States
  • PIH Health Hematology Medical Oncology ( Site 0106) Whittier, California, United States
View all 126 locations
View Trial Details
Active, Not Recruiting

A Study of NDI 1150-101 in Patients With Solid Tumors

NCT05128487

Conditions
Adenocarcinoma, Bronchial Neoplasms, Carcinoma, +36 more
Locations
  • Honor Health Research Institute Scottsdale, Arizona, United States
  • Yale Cancer Center New Haven, Connecticut, United States
  • Georgetown University Washington D.C., District of Columbia, United States
  • Ocala Oncology Center Ocala, Florida, United States
View all 19 locations
View Trial Details
Active, Not Recruiting

A Phase 1/2a Study of 23ME-00610 in Patients With Advanced Solid Malignancies

NCT05199272

Conditions
Adenocarcinoma, Adnexal Diseases, Bronchial Neoplasms, +45 more
Locations
  • Stanford Cancer Institute Palo Alto, California, United States
  • Emory University Atlanta, Georgia, United States
  • Karmanos Cancer Institute Detroit, Michigan, United States
  • R.J.Zuckerberg Cancer Center Lake Success, New York, United States
View all 13 locations
View Trial Details

Related conditions